Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease

The persistence or recurrence of symptoms in patients with coeliac disease (CD), despite a gluten-free diet (GFD), must prompt further work-up for excluding refractory CD (RCD). The aim of this study was to assess the accuracy of serum markers in predicting refractoriness in CD patients. This study...

Full description

Bibliographic Details
Main Authors: Marco Vincenzo Lenti, Nicola Aronico, Paolo Giuffrida, Valentina Antoci, Giovanni Santacroce, Alessandro Vanoli, Catherine Klersy, Gino Roberto Corazza, Antonio Di Sabatino
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/10/2289
_version_ 1797534571645894656
author Marco Vincenzo Lenti
Nicola Aronico
Paolo Giuffrida
Valentina Antoci
Giovanni Santacroce
Alessandro Vanoli
Catherine Klersy
Gino Roberto Corazza
Antonio Di Sabatino
author_facet Marco Vincenzo Lenti
Nicola Aronico
Paolo Giuffrida
Valentina Antoci
Giovanni Santacroce
Alessandro Vanoli
Catherine Klersy
Gino Roberto Corazza
Antonio Di Sabatino
author_sort Marco Vincenzo Lenti
collection DOAJ
description The persistence or recurrence of symptoms in patients with coeliac disease (CD), despite a gluten-free diet (GFD), must prompt further work-up for excluding refractory CD (RCD). The aim of this study was to assess the accuracy of serum markers in predicting refractoriness in CD patients. This study included 72 patients affected by CD followed-up at our center, namely 49 uncomplicated CD before and after GFD and 23 RCD. Serum levels of chromogranin A (CgA) and β2-microglobuline were measured at baseline and at follow-up (median time of 13 months) in each group of patients. Cut-off points for each marker were estimated to differentiate RCD from uncomplicated CD patients. Serum levels of CgA and β2-microglobuline were significantly higher in patients with RCD compared to uncomplicated CD (<i>p</i> < 0.001), both at baseline and at follow-up, with no significant difference between RCD type 1 and type 2. The estimated cut-off point for CgA was 90.2 ng/mL (sensitivity 83%, specificity 100%), while for β2-microglobuline it was 696 mcg/L (sensitivity 100%, specificity of 100%). To conclude, CgA and β2-microglobuline could be useful serological markers of refractoriness in CD, with the ability to discriminate those patients who should undergo upper gastrointestinal endoscopy for making a definite diagnosis.
first_indexed 2024-03-10T11:32:25Z
format Article
id doaj.art-1b14c96cadab4bf0be242901f6a9b2ea
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T11:32:25Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-1b14c96cadab4bf0be242901f6a9b2ea2023-11-21T19:07:25ZengMDPI AGCancers2072-66942021-05-011310228910.3390/cancers13102289Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac DiseaseMarco Vincenzo Lenti0Nicola Aronico1Paolo Giuffrida2Valentina Antoci3Giovanni Santacroce4Alessandro Vanoli5Catherine Klersy6Gino Roberto Corazza7Antonio Di Sabatino8Department of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyAnatomic Pathology Unit, IRCCS San Matteo Hospital Foundation, Department of Molecular Medicine, University of Pavia, 27100 Pavia, ItalyClinical Epidemiology and Biometry, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyDepartment of Internal Medicine, IRCCS San Matteo Hospital Foundation, University of Pavia, 27100 Pavia, ItalyThe persistence or recurrence of symptoms in patients with coeliac disease (CD), despite a gluten-free diet (GFD), must prompt further work-up for excluding refractory CD (RCD). The aim of this study was to assess the accuracy of serum markers in predicting refractoriness in CD patients. This study included 72 patients affected by CD followed-up at our center, namely 49 uncomplicated CD before and after GFD and 23 RCD. Serum levels of chromogranin A (CgA) and β2-microglobuline were measured at baseline and at follow-up (median time of 13 months) in each group of patients. Cut-off points for each marker were estimated to differentiate RCD from uncomplicated CD patients. Serum levels of CgA and β2-microglobuline were significantly higher in patients with RCD compared to uncomplicated CD (<i>p</i> < 0.001), both at baseline and at follow-up, with no significant difference between RCD type 1 and type 2. The estimated cut-off point for CgA was 90.2 ng/mL (sensitivity 83%, specificity 100%), while for β2-microglobuline it was 696 mcg/L (sensitivity 100%, specificity of 100%). To conclude, CgA and β2-microglobuline could be useful serological markers of refractoriness in CD, with the ability to discriminate those patients who should undergo upper gastrointestinal endoscopy for making a definite diagnosis.https://www.mdpi.com/2072-6694/13/10/2289β2-microglobulinechromogranin Arefractory coeliac diseaseserum markers
spellingShingle Marco Vincenzo Lenti
Nicola Aronico
Paolo Giuffrida
Valentina Antoci
Giovanni Santacroce
Alessandro Vanoli
Catherine Klersy
Gino Roberto Corazza
Antonio Di Sabatino
Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
Cancers
β2-microglobuline
chromogranin A
refractory coeliac disease
serum markers
title Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
title_full Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
title_fullStr Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
title_full_unstemmed Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
title_short Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
title_sort serum markers of refractoriness and enteropathy associated t cell lymphoma in coeliac disease
topic β2-microglobuline
chromogranin A
refractory coeliac disease
serum markers
url https://www.mdpi.com/2072-6694/13/10/2289
work_keys_str_mv AT marcovincenzolenti serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT nicolaaronico serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT paologiuffrida serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT valentinaantoci serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT giovannisantacroce serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT alessandrovanoli serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT catherineklersy serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT ginorobertocorazza serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease
AT antoniodisabatino serummarkersofrefractorinessandenteropathyassociatedtcelllymphomaincoeliacdisease